How should I interpret a low white blood cell count (3.87 ×10⁹/L), mildly elevated serum chloride (108 mmol/L), borderline high low‑density lipoprotein cholesterol (113 mg/dL), and insufficient 25‑hydroxyvitamin D level (21.5 ng/mL) in an adult?

Interpretation of Laboratory Results

Your white blood cell count of 3.87 × 10⁹/L is at the lower end of normal and does not require immediate intervention in an asymptomatic adult, particularly if you are of African descent; the chloride of 108 mmol/L is mildly elevated but clinically insignificant; the LDL of 113.2 mg/dL is borderline high and warrants lifestyle modification; and the vitamin D level of 21.5 ng/mL represents insufficiency requiring supplementation.

---

White Blood Cell Count: 3.87 × 10⁹/L

Assessment

• Your WBC count of 3.87 × 10⁹/L falls within the lower range of normal for the general population (typical reference range 4.0–11.0 × 10⁹/L), but this requires race-specific interpretation 1.
• If you are of African descent, this WBC count is entirely normal. Non-Hispanic Black adults have a reference range of 3.1–9.9 × 10⁹/L for males and 3.4–11.0 × 10⁹/L for females, making your value well within expected limits 1.
• For non-Black individuals, a WBC of 3.87 is at the lower boundary but still acceptable if you have no symptoms of infection, no history of recurrent infections, and no other concerning findings 1.

When to Investigate Further

• Repeat the CBC if you develop recurrent infections, unexplained fevers, or oral ulcers.
• Check an absolute neutrophil count (ANC) if not already provided—an ANC below 1.5 × 10⁹/L would warrant hematology consultation 2.
• Consider medication review: certain drugs (chemotherapy, immunosuppressants, some antibiotics) can lower WBC counts.

Common Pitfall

• Do not assume a WBC of 3.87 is abnormal without considering race-specific reference ranges. African Americans have physiologically lower WBC counts without increased infection risk, and applying Caucasian reference ranges leads to unnecessary workup 1.

---

Chloride: 108 mmol/L

Assessment

• A chloride level of 108 mmol/L is mildly elevated above the typical upper limit of 106 mmol/L, but this is clinically insignificant in isolation and does not indicate disease.
• Mild hyperchloremia (106–110 mmol/L) is commonly seen with dehydration, high dietary salt intake, or as a compensatory response to metabolic alkalosis.

When to Investigate Further

• If accompanied by low bicarbonate (CO₂ < 22 mmol/L), consider non-anion gap metabolic acidosis (e.g., diarrhea, renal tubular acidosis).
• If accompanied by high bicarbonate (CO₂ > 30 mmol/L), this may reflect compensation for chronic respiratory acidosis.
• Recheck electrolytes if you have symptoms of acid-base disturbance (confusion, rapid breathing, muscle weakness).

Action

• No specific intervention is needed for chloride of 108 mmol/L in an asymptomatic individual.
• Ensure adequate hydration and recheck with a basic metabolic panel if symptoms develop.

---

LDL Cholesterol: 113.2 mg/dL

Assessment

• An LDL of 113.2 mg/dL is classified as borderline high (100–129 mg/dL range) and indicates increased cardiovascular risk, particularly if other risk factors are present.
• Vitamin D deficiency (your level of 21.5 ng/mL) is independently associated with higher LDL cholesterol. In multivariable-adjusted analyses, deficient vitamin D is linked to 13.5% higher directly measured LDL-C compared to optimal levels 3.
• Vitamin D deficiency is also associated with an atherogenic lipid profile including higher triglycerides, VLDL, and remnant lipoproteins 3, 4.

Management Algorithm

1. Initiate vitamin D supplementation (see below)—correcting vitamin D insufficiency may improve your lipid profile 3, 4.
2. Lifestyle modification:
   • Reduce saturated fat intake to < 7% of total calories.
   • Increase soluble fiber (oats, beans, fruits) to 10–25 grams daily.
   • Aim for 150 minutes of moderate-intensity aerobic exercise weekly.
   • Achieve and maintain healthy body weight (BMI 18.5–24.9).
3. Recheck fasting lipid panel in 3 months after vitamin D repletion and lifestyle changes.
4. Consider statin therapy if:
   • LDL remains ≥ 130 mg/dL after 3 months of lifestyle modification.
   • You have diabetes, known cardiovascular disease, or 10-year ASCVD risk ≥ 7.5% (calculate using pooled cohort equations).

Common Pitfall

• Do not ignore borderline-high LDL (100–129 mg/dL) in the presence of vitamin D deficiency. The combination significantly increases cardiovascular risk, and correcting vitamin D may reduce LDL by up to 13% 3.

---

Vitamin D: 21.5 ng/mL

Assessment

• A serum 25-hydroxyvitamin D level of 21.5 ng/mL is classified as insufficiency (20–30 ng/mL range), falling short of the optimal target of ≥ 30 ng/mL 5.
• Vitamin D insufficiency is associated with:
  • Elevated LDL cholesterol and atherogenic lipid profile (as seen in your case) 3, 4.
  • Increased cardiovascular risk 3.
  • Suboptimal bone health and increased fracture risk 5.
  • Secondary hyperparathyroidism and elevated bone turnover 5.

Treatment Protocol

Start oral vitamin D₃ (cholecalciferol) supplementation immediately:

• Option 1 (Preferred for faster correction): 50,000 IU once weekly for 8 weeks, then transition to maintenance 5.
• Option 2 (Daily dosing): Add 1,000 IU daily to your current intake and recheck in 3 months 5.
• Maintenance after repletion: 800–1,000 IU daily to sustain levels ≥ 30 ng/mL 5.

Monitoring

• Recheck serum 25(OH)D in 3 months after starting supplementation to confirm achievement of target level (≥ 30 ng/mL) 5.
• Once stable at ≥ 30 ng/mL, annual monitoring is sufficient 5.

Calcium Co-Supplementation

• Ensure total calcium intake of 1,000–1,200 mg daily from diet plus supplements if needed 5.
• Calcium supplements should be taken in divided doses (maximum 600 mg per dose) for optimal absorption 5.

Expected Benefits

• Achieving 25(OH)D ≥ 30 ng/mL is associated with:
  • 20% reduction in non-vertebral fractures 5.
  • 18% reduction in hip fractures 5.
  • 19% reduction in fall risk 5.
  • Improvement in atherogenic lipid profile, including reduction in LDL cholesterol 3, 4.

Safety

• Daily doses up to 4,000 IU are completely safe for adults 5.
• Toxicity is rare and occurs only with prolonged daily doses > 10,000 IU or serum levels > 100 ng/mL 5.

Common Pitfalls

• Do not delay supplementation waiting for "more testing." Your level of 21.5 ng/mL clearly indicates insufficiency requiring treatment 5.
• Do not use vitamin D₂ (ergocalciferol) for maintenance. Vitamin D₃ (cholecalciferol) maintains serum levels longer and has superior bioavailability 5.
• Do not measure vitamin D levels earlier than 3 months after starting supplementation, as levels need time to plateau 5.
• Do not ignore the link between vitamin D insufficiency and your borderline-high LDL. Correcting vitamin D may improve your lipid profile 3, 4.

---

Summary Action Plan

1. Start vitamin D₃ 50,000 IU once weekly for 8 weeks, then 800–1,000 IU daily maintenance 5.
2. Ensure calcium intake of 1,000–1,200 mg daily from diet and supplements 5.
3. Implement lifestyle modifications for LDL reduction: reduce saturated fat, increase fiber, exercise 150 minutes weekly.
4. Recheck labs in 3 months:
   • Serum 25(OH)D (target ≥ 30 ng/mL) 5.
   • Fasting lipid panel (goal LDL < 100 mg/dL).
   • Basic metabolic panel (to reassess chloride if symptomatic).
5. No immediate action needed for WBC 3.87 if you are asymptomatic and of African descent 1; otherwise, monitor for symptoms and recheck if concerns arise.